link
Bookmarks
Nasal Septal Perforation
Luke N. Ledbetter, MD; Michelle A. Michel, MD
To access 4,300 diagnoses written by the world's leading experts in radiology, please log in or subscribe.Log inSubscribe

DIFFERENTIAL DIAGNOSIS

    ESSENTIAL INFORMATION

    • Key Differential Diagnosis Issues

      • Helpful Clues for Common Diagnoses

        • Helpful Clues for Less Common Diagnoses

          • Helpful Clues for Rare Diagnoses

            Selected References

            1. D'Anza B et al: Sinonasal imaging findings in granulomatosis with polyangiitis (Wegener granulomatosis): A systematic review. Am J Rhinol Allergy. 31(1):16-21, 2017
            2. Geltzeiler M et al: Nasal septal perforation secondary to systemic bevacizumab. Am J Otolaryngol. 38(3):354-355, 2017
            3. Gold M et al: Imaging prevalence of nasal septal perforation in an urban population. Clin Imaging. 43:80-82, 2017
            4. Lanier B et al: Pathophysiology and progression of nasal septal perforation. Ann Allergy Asthma Immunol. 99(6):473-9; quiz 480-1, 521, 2007
            5. Eggesbø HB: Radiological imaging of inflammatory lesions in the nasal cavity and paranasal sinuses. Eur Radiol. 16(4):872-88, 2006
            6. Ramiscal JA et al. Bevacizumab-induced nasal septal perforation: incidence of symptomatic, confirmed event(s) in colorectal cancer patients. Acta Oncol. 2011 May;50(4):578-81.
            Related Anatomy
            Loading...
            Related Differential Diagnoses
            Loading...
            References
            Tables

            Tables

            DIFFERENTIAL DIAGNOSIS

              ESSENTIAL INFORMATION

              • Key Differential Diagnosis Issues

                • Helpful Clues for Common Diagnoses

                  • Helpful Clues for Less Common Diagnoses

                    • Helpful Clues for Rare Diagnoses

                      Selected References

                      1. D'Anza B et al: Sinonasal imaging findings in granulomatosis with polyangiitis (Wegener granulomatosis): A systematic review. Am J Rhinol Allergy. 31(1):16-21, 2017
                      2. Geltzeiler M et al: Nasal septal perforation secondary to systemic bevacizumab. Am J Otolaryngol. 38(3):354-355, 2017
                      3. Gold M et al: Imaging prevalence of nasal septal perforation in an urban population. Clin Imaging. 43:80-82, 2017
                      4. Lanier B et al: Pathophysiology and progression of nasal septal perforation. Ann Allergy Asthma Immunol. 99(6):473-9; quiz 480-1, 521, 2007
                      5. Eggesbø HB: Radiological imaging of inflammatory lesions in the nasal cavity and paranasal sinuses. Eur Radiol. 16(4):872-88, 2006
                      6. Ramiscal JA et al. Bevacizumab-induced nasal septal perforation: incidence of symptomatic, confirmed event(s) in colorectal cancer patients. Acta Oncol. 2011 May;50(4):578-81.